Pharmacology & Toxicologynpj Drug Discovery.Peer-reviewed
Cystobactamid off-target profiling reveals favorable safety, superoxide reduction, and SCARB1 inhibition in eukaryotes
Timo Risch, Benedikt Hellwinkel, Dietrich Mostert…·Rolf Müller
This study profiles cystobactamids' off-target effects in eukaryotes, showing safety, superoxide reduction, and SCARB1 inhibition with therapeutic potential.
1 citation